What are the Future Trends in Regulatory Reporting for Cancer?
The future of regulatory reporting in cancer is likely to be influenced by several trends:
Increased use of real-world evidence to complement clinical trial data Greater emphasis on patient-centered outcomes Integration of wearable technology for real-time data collection Enhanced collaboration between regulatory bodies and pharmaceutical companies Continued development of global standards for data sharing and reporting
